記住我
J.A.B. is a consultant for Amgen. D.O.K. is a consultant for Amgen, Immunovant and Lassen Therapeutics. T.J.S. has issued patents for targeting IGF-IR as a therapy for autoimmune diseases, including TED, which are held by Lundquist Institute/UCLA and University of Michigan. T.J.S. is a consultant for Amgen, Viridian Therapeutics, Lundbeck, Argenx, Lassen Therapeutics and Minghui Pharmaceuticals.
留言 (0)